NPPA issued the retail price for the Factor VIII IP (1000 IU) + Protein content IP (≤ 80 g/L) + Sodium Chloride IP (≤ 250 mM) + Sodium Citrate IP (≤ 10 mM) + Calcium Chloride IP (≤ 1 mM) + Mannitol IP (≤7.6 % w/v) + Glycine IP (≤ 300 mM) + Lycine HCL BP (≤ 25 mM) + Sucrose IP (≤ 1% w/v) + Sodium ion content IP (≤ 200 mM/L) + Fibrinogen content (of total protein) (≤ 80%) for M/s Reliance Life Sciences Pvt. Ltd. (Manufacturer & Marketer)

Mar 08, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 05, 2026, issued the retail price for the Factor VIII IP (1000 IU) + Protein content IP (≤ 80 g/L) + Sodium Chloride IP (≤ 250 mM) + Sodium Citrate IP (≤ 10 mM) + Calcium Chloride IP (≤ 1 mM) + Mannitol IP (≤7.6 % w/v) + Glycine IP (≤ 300 mM) + Lycine HCL BP (≤ 25 mM) + Sucrose IP (≤ 1% w/v) + Sodium ion content IP (≤ 200 mM/L) + Fibrinogen content (of total protein) (≤ 80%) for M/s Reliance Life Sciences Pvt. Ltd. (Manufacturer & Marketer).

The following are the Calculation of retail price:

• Derived Retail price for Human Coagulation Factor VIII IP (1000 IU) (Note 1) - Rs. 14,666.35 per vial 

• Claimed Price Rs. 17,334.00 per vial 

• Recommended retail price (Lower of worked out and claimed price) - Rs. 14,666.35 per vial

[Notification No. 19(4970)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT